• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ACHN 细胞来源的外泌体 microRNA-15a 通过 BTG2/PI3K/AKT 轴加重肾透明细胞癌。

Exosomal microRNA-15a from ACHN cells aggravates clear cell renal cell carcinoma via the BTG2/PI3K/AKT axis.

机构信息

Department of Urology, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou, China.

Department of Otorhinolaryngology - Head and Neck Surgery, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou, China.

出版信息

Kaohsiung J Med Sci. 2021 Nov;37(11):973-982. doi: 10.1002/kjm2.12428. Epub 2021 Aug 1.

DOI:10.1002/kjm2.12428
PMID:34337864
Abstract

Accumulating studies have indicated that exosomal microRNAs (miRNAs/miRs) can mediate clear cell renal cell carcinoma (ccRCC) at the early stage, but the mechanisms remain to be specified. Here, we investigated the mechanism of exosomal miR-15a in ccRCC. After successful isolation of exosomes from RCC cells, we found that miR-15a was upregulated in ccRCC cells. Moreover, upregulation of miR-15a by pre-miR-15a promoted the proliferation, migration, invasion, and epithelial-mesenchymal transition of ccRCC cells. A luciferase assay revealed that B-cell translocation gene 2 (BTG2) was a target gene of miR-15a and negatively correlated with miR-15a expression. BTG2 was poorly expressed in ccRCC, which reduced the proliferation of ccRCC cells. In addition, overexpression of BTG2 could reverse the promotive effects of miR-15a on ccRCC. Furthermore, BTG2 reduced PI3K/AKT pathway activity. Our results collectively indicated that exosomal miR-15a from RCC cells accelerated cell viability by downregulating BTG2 and promoting the activity of the PI3K/AKT signaling pathway. We demonstrated a novel mechanism by which exosomal miR-15a exerted pro-proliferatory effects on ccRCC, highlighting the potential of exosomal miR-15a as a target for ccRCC prognosis.

摘要

越来越多的研究表明,外泌体 microRNAs(miRNAs/miRs)可以在早期介导透明细胞肾细胞癌(ccRCC),但其机制尚待明确。在此,我们研究了外泌体 miR-15a 在 ccRCC 中的作用机制。成功从 RCC 细胞中分离出外泌体后,我们发现 miR-15a 在 ccRCC 细胞中上调。此外,通过 pre-miR-15a 上调 miR-15a 促进了 ccRCC 细胞的增殖、迁移、侵袭和上皮-间充质转化。荧光素酶报告基因实验显示 B 细胞易位基因 2(BTG2)是 miR-15a 的靶基因,与 miR-15a 表达呈负相关。BTG2 在 ccRCC 中低表达,降低了 ccRCC 细胞的增殖能力。此外,过表达 BTG2 可以逆转 miR-15a 对 ccRCC 的促进作用。此外,BTG2 降低了 PI3K/AKT 通路的活性。我们的研究结果表明,来自 RCC 细胞的外泌体 miR-15a 通过下调 BTG2 并促进 PI3K/AKT 信号通路的活性,加速了细胞活力。我们证明了外泌体 miR-15a 对 ccRCC 发挥促增殖作用的新机制,突出了外泌体 miR-15a 作为 ccRCC 预后靶点的潜力。

相似文献

1
Exosomal microRNA-15a from ACHN cells aggravates clear cell renal cell carcinoma via the BTG2/PI3K/AKT axis.ACHN 细胞来源的外泌体 microRNA-15a 通过 BTG2/PI3K/AKT 轴加重肾透明细胞癌。
Kaohsiung J Med Sci. 2021 Nov;37(11):973-982. doi: 10.1002/kjm2.12428. Epub 2021 Aug 1.
2
Inhibitor of growth 4 inhibits cell proliferation, migration, and induces apoptosis of renal cell carcinoma cells.生长抑制剂 4 可抑制肾癌细胞的增殖、迁移,并诱导其凋亡。
J Cell Biochem. 2019 Apr;120(4):6709-6717. doi: 10.1002/jcb.27967. Epub 2018 Nov 2.
3
MicroRNA-203 inhibits epithelial-mesenchymal transition, migration, and invasion of renal cell carcinoma cells via the inactivation of the PI3K/AKT signaling pathway by inhibiting CAV1.MicroRNA-203 通过抑制 Cav1 使 PI3K/AKT 信号通路失活,从而抑制肾透明细胞癌细胞的上皮-间充质转化、迁移和侵袭。
Cell Adh Migr. 2020 Dec;14(1):227-241. doi: 10.1080/19336918.2020.1827665.
4
miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.miRNA-205-5p 通过负调控肾癌细胞中的 VEGFA 和 PI3K/Akt/mTOR 信号通路发挥肿瘤抑制作用。
Oncol Rep. 2019 Nov;42(5):1677-1688. doi: 10.3892/or.2019.7307. Epub 2019 Sep 10.
5
IFI16 promotes the progression of clear cell renal cell carcinoma through the IL6/PI3K/AKT axis.IFI16 通过 IL6/PI3K/AKT 轴促进肾透明细胞癌的进展。
J Transl Med. 2024 Jun 3;22(1):533. doi: 10.1186/s12967-024-05354-w.
6
The putative tumor suppressor microRNA-30a-5p modulates clear cell renal cell carcinoma aggressiveness through repression of ZEB2.假定的肿瘤抑制因子微小RNA-30a-5p通过抑制ZEB2来调节肾透明细胞癌的侵袭性。
Cell Death Dis. 2017 Jun 1;8(6):e2859. doi: 10.1038/cddis.2017.252.
7
M2 macrophage-derived exosomal microRNAs inhibit cell migration and invasion in gliomas through PI3K/AKT/mTOR signaling pathway.M2 巨噬细胞来源的外泌体 microRNAs 通过 PI3K/AKT/mTOR 信号通路抑制胶质瘤细胞迁移和侵袭。
J Transl Med. 2021 Mar 6;19(1):99. doi: 10.1186/s12967-021-02766-w.
8
Delivery of miR-224-5p by Exosomes from Cancer-Associated Fibroblasts Potentiates Progression of Clear Cell Renal Cell Carcinoma.肿瘤相关成纤维细胞来源的外泌体递送 miR-224-5p 促进肾透明细胞癌进展。
Comput Math Methods Med. 2021 May 24;2021:5517747. doi: 10.1155/2021/5517747. eCollection 2021.
9
Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.靶向 SPP1 的 microRNA-340 通过抑制 PI3K/AKT 信号通路抑制胃癌细胞上皮-间充质转化。
J Cell Physiol. 2019 Aug;234(10):18587-18601. doi: 10.1002/jcp.28497. Epub 2019 Apr 5.
10
PLAUR facilitates the progression of clear cell renal cell carcinoma by activating the PI3K/AKT/mTOR signaling pathway.PLAUR 通过激活 PI3K/AKT/mTOR 信号通路促进肾透明细胞癌的进展。
PeerJ. 2024 Jun 27;12:e17555. doi: 10.7717/peerj.17555. eCollection 2024.

引用本文的文献

1
LncRNA SNHG5 modulates cell proliferation and migration through the miR-92a-3p/BTG2 axis in gastric cancer by the PI3K/AKT pathway.长链非编码RNA SNHG5通过PI3K/AKT途径,经miR-92a-3p/BTG2轴调控胃癌细胞的增殖和迁移。
World J Gastrointest Oncol. 2025 Aug 15;17(8):105321. doi: 10.4251/wjgo.v17.i8.105321.
2
Machine learning-assisted radiogenomic analysis for miR-15a expression prediction in renal cell carcinoma.机器学习辅助的放射基因组分析用于预测肾细胞癌中miR-15a的表达
BMC Cancer. 2025 Aug 20;25(1):1349. doi: 10.1186/s12885-025-13963-x.
3
Exosomal Biomarkers: A Comprehensive Overview of Diagnostic and Prognostic Applications in Malignant and Non-Malignant Disorders.

本文引用的文献

1
Systematic Analysis of microRNA Biomarkers for Diagnosis, Prognosis, and Therapy in Patients With Clear Cell Renal Cell Carcinoma.透明细胞肾细胞癌患者诊断、预后及治疗的微小RNA生物标志物的系统分析
Front Oncol. 2020 Dec 4;10:543817. doi: 10.3389/fonc.2020.543817. eCollection 2020.
2
MicroRNA Derived from Circulating Exosomes as Noninvasive Biomarkers for Diagnosing Renal Cell Carcinoma.循环外泌体来源的微小RNA作为诊断肾细胞癌的非侵入性生物标志物
Onco Targets Ther. 2020 Oct 23;13:10765-10774. doi: 10.2147/OTT.S271606. eCollection 2020.
3
The immunology of renal cell carcinoma.
外泌体生物标志物:恶性和非恶性疾病诊断及预后应用的全面概述
Biomolecules. 2025 Apr 15;15(4):587. doi: 10.3390/biom15040587.
4
Exosome in renal cell carcinoma progression and implications for targeted therapy.外泌体在肾细胞癌进展中的作用及对靶向治疗的意义。
Front Oncol. 2024 Sep 4;14:1458616. doi: 10.3389/fonc.2024.1458616. eCollection 2024.
5
Diagnostic, prognostic, and therapeutic potential of exosomal microRNAs in renal cancer.外泌体微小RNA在肾癌中的诊断、预后及治疗潜力
Pharmacol Rep. 2024 Apr;76(2):273-286. doi: 10.1007/s43440-024-00568-7. Epub 2024 Feb 22.
6
Biomarkers in renal cell carcinoma and their targeted therapies: a review.肾细胞癌中的生物标志物及其靶向治疗:综述
Explor Target Antitumor Ther. 2023;4(5):941-961. doi: 10.37349/etat.2023.00175. Epub 2023 Oct 25.
7
Exosomes in the Diagnosis and Treatment of Renal Cell Cancer.外泌体在肾细胞癌诊断与治疗中的应用
Int J Mol Sci. 2023 Sep 20;24(18):14356. doi: 10.3390/ijms241814356.
8
Extracellular vesicles in renal cell carcinoma: challenges and opportunities coexist.肾细胞癌中的细胞外囊泡:挑战与机遇并存。
Front Immunol. 2023 Jul 4;14:1212101. doi: 10.3389/fimmu.2023.1212101. eCollection 2023.
9
Role of microRNA carried by small extracellular vesicles in urological tumors.小细胞外囊泡携带的微小RNA在泌尿系统肿瘤中的作用
Front Cell Dev Biol. 2023 Jun 2;11:1192937. doi: 10.3389/fcell.2023.1192937. eCollection 2023.
10
Myocardial angiogenesis induced by concurrent vitamin D supplementation and aerobic-resistance training is mediated by inhibiting miRNA-15a, and miRNA-146a and upregulating VEGF/PI3K/eNOS signaling pathway.同时补充维生素D和进行有氧抗阻训练诱导的心肌血管生成是通过抑制miRNA - 15a和miRNA - 146a并上调VEGF/PI3K/eNOS信号通路介导的。
Pflugers Arch. 2023 Apr;475(4):541-555. doi: 10.1007/s00424-023-02788-x. Epub 2023 Jan 23.
肾细胞癌的免疫学。
Nat Rev Nephrol. 2020 Dec;16(12):721-735. doi: 10.1038/s41581-020-0316-3. Epub 2020 Jul 30.
4
Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinoma.PI3K/AKT/mTOR信号通路成员在透明细胞肾细胞癌中的预后意义
PeerJ. 2020 Jun 1;8:e9261. doi: 10.7717/peerj.9261. eCollection 2020.
5
Extracellular Vesicles Enriched in hsa-miR-301a-3p and hsa-miR-1293 Dynamics in Clear Cell Renal Cell Carcinoma Patients: Potential Biomarkers of Metastatic Disease.富含hsa-miR-301a-3p和hsa-miR-1293的细胞外囊泡在透明细胞肾细胞癌患者中的动态变化:转移性疾病的潜在生物标志物
Cancers (Basel). 2020 Jun 2;12(6):1450. doi: 10.3390/cancers12061450.
6
Extracellular Vesicles in Renal Cell Carcinoma: Multifaceted Roles and Potential Applications Identified by Experimental and Computational Methods.肾细胞癌中的细胞外囊泡:通过实验和计算方法确定的多方面作用及潜在应用
Front Oncol. 2020 May 7;10:724. doi: 10.3389/fonc.2020.00724. eCollection 2020.
7
Inhibition of circulating exosomal microRNA-15a-3p accelerates diabetic wound repair.抑制循环外泌体 microRNA-15a-3p 可加速糖尿病创面修复。
Aging (Albany NY). 2020 May 21;12(10):8968-8986. doi: 10.18632/aging.103143.
8
PTPN3 Inhibits the Growth and Metastasis of Clear Cell Renal Cell Carcinoma via Inhibition of PI3K/AKT Signaling.PTPN3 通过抑制 PI3K/AKT 信号通路抑制肾透明细胞癌的生长和转移。
Mol Cancer Res. 2020 Jun;18(6):903-912. doi: 10.1158/1541-7786.MCR-19-1142. Epub 2020 Mar 13.
9
mRNA destabilization by BTG1 and BTG2 maintains T cell quiescence.BTG1 和 BTG2 通过 mRNA 不稳定性维持 T 细胞静止。
Science. 2020 Mar 13;367(6483):1255-1260. doi: 10.1126/science.aax0194.
10
Up-regulated LINC01234 promotes non-small-cell lung cancer cell metastasis by activating VAV3 and repressing BTG2 expression.上调 LINC01234 通过激活 VAV3 和抑制 BTG2 表达促进非小细胞肺癌细胞转移。
J Hematol Oncol. 2020 Jan 20;13(1):7. doi: 10.1186/s13045-019-0842-2.